Suchergebnisse - (Person:"Esteve-Valverde, Enrique")

PubPharm (6)

1

Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS) : from theory to reality

enthalten in: Clinical rheumatology | 2024

von Udry, S. | Latino, J. | Perez, S. | +7

2

Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria'

enthalten in: Annals of the rheumatic diseases | 2024

von Miro-Mur, F. | Alijotas-Reig, J. | Anunciacion-Llunell, A. | +3

3

Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group

enthalten in: Placenta | 2023

von Esteve-Valverde, E. | Alijotas-Reig, J. | Belizna, C. | +30

ErratumIn: Placenta. 2023 May 3;138:20. - PMID 37146536

4

Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome

enthalten in: International journal of molecular sciences | 2022

von Anunciación-Llunell, A. | Muñoz, C. | Roggenbuck, D. | +5

5

Obstetrical outcome and treatments in seronegative primary APS : data from European retrospective study

enthalten in: RMD open | 2020

von Abisror, N. | Nguyen, Y. | Marozio, L. | +27

6

Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS) : report of 1640 cases from the EUROAPS registry

enthalten in: Rheumatology (Oxford, England) | 2020

von Alijotas-Reig, J. | Esteve-Valverde, E. | Ferrer-Oliveras, R. | +32

ErratumIn: Rheumatology (Oxford). 2021 Dec 1;60(12):5883. - PMID 34672326

1
[1]